# Study of Everolimus in de Novo Renal Transplant Recipients

> **NCT01609673** · NA · TERMINATED · sponsor: **Helady Pinheiro, MD, PhD** · enrollment: 1 (actual)

## Conditions studied

- End Stage Renal Failure With Renal Transplant

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01609673
- **Lead sponsor:** Helady Pinheiro, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** The inclusion of proposed sample turned to be infeasible due to Ethical Non-approval of 2 research sites and another site no transplant activity since 2012.
- **Last updated:** 2013-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01609673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01609673, "Study of Everolimus in de Novo Renal Transplant Recipients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01609673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*